Sign in

You're signed outSign in or to get full access.

Joan T. Dea

Director at SCHWAB CHARLESSCHWAB CHARLES
Board

About Joan T. Dea

Independent director of The Charles Schwab Corporation; age 61; director since 2017 (current term expires 2027). Background: Managing Director and founder of Beckwith Investments LLC (2008–present); prior Executive Committee member at BMO Financial Group (EVP, Strategic Management & Corporate Marketing) and Partner/Director at Boston Consulting Group (financial services practice leader). She has served on the Board of Directors of Charles Schwab Bank (CSB) since 2011. Core credentials: public company leadership and governance, financial services strategy, and marketing/finance expertise .

Past Roles

OrganizationRoleTenureCommittees/Impact
Beckwith Investments LLCManaging Director (Founder)2008–presentPrivate investment/consulting; strategic capital deployment
BMO Financial GroupExecutive Committee; EVP Strategic Management & Corporate Marketing2003–2008Enterprise strategy and corporate marketing leadership
Boston Consulting GroupPartner & Director; Global Financial Services practice leader1994–2003Led advisory to banks/asset managers; operating strategy

External Roles

OrganizationRoleTenureNotes
Cineplex Inc.Director2006–May 2025Retirement effective May 2025
Performance Sports Group Ltd.Director2015–2017Prior public board
Torstar CorporationDirector2009–2015Prior public board

Board Governance

  • Committee assignments: Compensation Committee (member) and Nominating & Corporate Governance Committee (member) .
  • Independence: Board determined Dea is independent under NYSE standards; board noted her spouse serves as a trustee of a nonprofit to which the company or its affiliates have made donations and concluded independence remains intact .
  • Attendance and engagement: Board held eight meetings in 2024; each director attended at least 75% of applicable board and committee meetings. Compensation Committee held eight meetings; Nominating & Corporate Governance Committee held five meetings in 2024 .
  • Leadership context: Executive sessions of non-management directors are held regularly; Chair of Nominating & Corporate Governance (Frank C. Herringer) leads independent director sessions (Dea is a committee member, not chair) .

Fixed Compensation

Component2024 AmountTerms
Annual cash retainer (non-employee director)$100,000Standard board cash retainer
Committee membership fees$15,000 per committeeCompensation Committee member $15,000; Nominating & Corporate Governance member $15,000
CSB (bank) board cash retainerIncluded in cash totalDea’s cash column includes CSB board retainer per footnote (amount not itemized)
Equity grant (aggregate value)$215,00060% RSUs; 40% stock options; annual grants on second business day after annual meeting
Vesting (RSUs)Time-based25% on first anniversary; 25% on second; 50% on third; accelerates on death/disability/retirement
Options—term & expiryTime-basedExpire at earliest of 10 years after grant, 3 months post-service (non-retirement), or 1 year post death/disability
Exercise price policyAt/above marketUnder plan, option exercise price cannot be less than closing price on grant date
2024 Director Compensation (Joan T. Dea)Amount ($)
Fees Earned or Paid in Cash$165,000
Deferred into RSUs or Options (DCP2)— (none)
Stock Awards (RSUs grant-date fair value)$129,027
Option Awards (grant-date fair value)$86,008
Total$380,035

Performance Compensation

  • Directors do not have performance-based pay metrics. Annual director equity is time-based (RSUs and options per vesting schedule above); no director performance metrics disclosed (PBRSU metrics apply to executives, not directors) .

Other Directorships & Interlocks

  • Current/Recent public company boards: Cineplex Inc. (retiring May 2025), prior boards Performance Sports Group Ltd. and Torstar Corporation .
  • Interlocks/potential conflicts: Board considered that Dea’s spouse is a trustee at a nonprofit receiving donations from the company/affiliates; determined independence remains; ordinary-course credit transactions for directors/affiliates are permitted on market terms and reviewed under the related-party policy .

Expertise & Qualifications

  • Qualifications cited by SCHW: public company executive and board experience; financial services, banking, asset management, brokerage/investment banking; strategic planning; finance; marketing; international business; ESG .

Equity Ownership

MetricValue
Shares owned (as of March 3, 2025)22,016
Right to acquire within 60 days (likely options exercisable)31,076
Total beneficial ownership53,092; less than 1% of outstanding shares
Outstanding awards (as of Dec 31, 2024)Stock options: 40,371; RSUs: 4,708
Director stock ownership guidelineMinimum $400,000 FMV; expected within 5 years; RSUs included; options excluded
Guideline complianceAll directors compliant as of Dec 31, 2024
Hedging/pledging policyProhibits speculative trading/hedging and pledging of company securities
Section 16 filing statusNo delinquent filings disclosed for Dea in 2024 (late reports noted for others)

Governance Assessment

  • Strengths: Independent director with deep financial services and strategy background; active on Compensation and Nominating & Corporate Governance—two high-leverage committees for pay design, ESG oversight, succession, and board evaluations; strong engagement implied by committee load and board-wide attendance standards .
  • Pay/Alignment: Balanced director pay mix (cash + equity); standard vesting; ownership guideline ($400k) met at board level; prohibitions on hedging/pledging enhance alignment and mitigate risk .
  • Consultant independence and pay governance: Compensation Committee (including Dea) engages Semler Brossy; independence affirmed; peer benchmarking and risk review processes robust (signals disciplined pay governance) .
  • Potential conflicts: Spouse trustee donation relationship noted and assessed; board concluded independence under NYSE standards; related-party transactions governed by formal policy with Audit Committee review thresholds (≥$120,000) .
  • RED FLAGS: None material disclosed for Dea. No pledging/hedging permitted; no delinquent Section 16 filings for Dea; attendance threshold met; director equity not performance-linked (typical for directors) .